Generate a tailored SOP for Dr. Jason Cheng. Improve your application with a focused, well-structured draft.
Dr. Jason Cheng is a board-certified hematopathologist and cancer biologist at the University of Chicago. He completed his medical education and training in Medicine and Pathology at Kunming Medical University and Beijing Medical University in China. He received his PhD in Molecular Pharmacology, where he collaborated with notable figures such as Professor Rudy Juliano and Professor Victor Ling on multidrug resistance proteins. Dr. Cheng also trained in Molecular Biology & Gene Regulation, as a postdoctoral fellow under Professor Mark Ptashne, who is a recipient of the 1997 Lasker Basic Research Award. His research encompasses hematologic diseases, particularly myelodysplastic syndromes (MDS), aplastic anemia, myeloproliferative neoplasms, and acute myeloid leukemia (AML). Dr. Cheng has received multiple awards, including the 2008 USCAP-SH Pathologist-in-Training Award and the 2019 Taub Medical Foundation MDS Award, for his work on epigenetic mechanisms in leukemia and cancer. He is actively engaged in developing novel RNA epigenetics-driven diagnostics and therapeutics.
Beijing Medical University • Beijing, China
Taught and conducted research in the field of hematopathology.
Rudy Juliano Lab • UNC Chapel Hill
Focused on pharmacology and molecular mechanisms of drug resistance.
University of Chicago • Chicago, IL
Trained in diagnostic hematopathology under Dr. James Vardiman.
Department of Philosophy